论文部分内容阅读
对发病率高、病情进展快的乡镇企业矽肺患者１５例（另１４例为病情相近的对照组）经纤支镜滴入克矽平（Ｐ２０４）治疗，每６月滴一次，二年后（滴入总量５．７６克）疗效观察：从Ｘ线胸片分析，治疗组无进展（好转＋稳定）占７３．３％，对照组进展占７５．０％。并由症状，死亡病例数，血清、支气管肺泡灌洗液、肺功能某些项目检测结果初步表明滴入克矽平治疗矽肺的有效性。且此法不良反应轻微，病人多能耐受。
15 cases of silicosis patients (the other 14 cases were similar control group) with high morbidity and rapid disease progression were treated with P204 by bronchofiberscopy and dripped every 6 months. Two years later Into the total amount of 5.76 grams) Efficacy of observation: From the X-ray analysis, the treatment group no progress (improvement + stability) accounted for 73.3%, the control group accounted for 75.0%. And by the symptoms, the number of deaths, serum, bronchoalveolar lavage fluid, pulmonary function test results of some of the items initially showed the drop of Kexit Ping effective treatment of silicosis. And this method mild adverse reactions, the patient can tolerate.